Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

A case of apathy due to frontotemporal dementia responsive to memantine.

Links KA, Black SE, Graff-Guerrero A, Wilson AA, Houle S, Pollock BG, Chow TW.

Neurocase. 2013;19(3):256-61. doi: 10.1080/13554794.2012.667120. Epub 2012 Apr 19.

PMID:
22515731
2.

Memantine for behavioral disturbances in frontotemporal dementia: a case series.

Swanberg MM.

Alzheimer Dis Assoc Disord. 2007 Apr-Jun;21(2):164-6.

PMID:
17545743
3.

Off-label medication use in frontotemporal dementia.

Bei Hu, Ross L, Neuhaus J, Knopman D, Kramer J, Boeve B, Caselli RJ, Graff-Radford N, Mendez MF, Miller BL, Boxer AL.

Am J Alzheimers Dis Other Demen. 2010 Mar;25(2):128-33. doi: 10.1177/1533317509356692. Epub 2010 Feb 1.

4.

Memantine in behavioral variant frontotemporal dementia: negative results.

Vercelletto M, Boutoleau-Bretonnière C, Volteau C, Puel M, Auriacombe S, Sarazin M, Michel BF, Couratier P, Thomas-Antérion C, Verpillat P, Gabelle A, Golfier V, Cerato E, Lacomblez L; French research network on Frontotemporal dementia.

J Alzheimers Dis. 2011;23(4):749-59. doi: 10.3233/JAD-2010-101632.

PMID:
21157021
5.

Impact of Imaging and Cerebrospinal Fluid Biomarkers on Behavioral Variant Frontotemporal Dementia Diagnosis within a Late-Onset Frontal Lobe Syndrome Cohort.

Krudop WA, Dols A, Kerssens CJ, Prins ND, Möller C, Schouws S, Barkhof F, van Berckel BN, Teunissen CE, van der Flier WM, Scheltens P, Sikkes SA, Stek ML, Pijnenburg YA.

Dement Geriatr Cogn Disord. 2016;41(1-2):16-26. doi: 10.1159/000441023. Epub 2015 Oct 17.

PMID:
26473985
6.

Apathy in frontotemporal dementia: behavioral and neuroimaging correlates.

Eslinger PJ, Moore P, Antani S, Anderson C, Grossman M.

Behav Neurol. 2012;25(2):127-36. doi: 10.3233/BEN-2011-0351.

7.

Bupropion improved apathy in behavioral variant frontotemporal dementia: a case report.

Lin CP, Chu CP, Liu HC.

Neurocase. 2016 Oct;22(5):466-468. Epub 2016 Aug 2.

PMID:
27484407
8.

First Symptoms and Neurocognitive Correlates of Behavioral Variant Frontotemporal Dementia.

Santamaría-García H, Reyes P, García A, Baéz S, Martinez A, Santacruz JM, Slachevsky A, Sigman M, Matallana D, Ibañez A.

J Alzheimers Dis. 2016 Oct 4;54(3):957-970.

PMID:
27567867
9.

White matter disease contributes to apathy and disinhibition in behavioral variant frontotemporal dementia.

Powers JP, Massimo L, McMillan CT, Yushkevich PA, Zhang H, Gee JC, Grossman M.

Cogn Behav Neurol. 2014 Dec;27(4):206-14. doi: 10.1097/WNN.0000000000000044.

10.

The added value of 18-fluorodeoxyglucose-positron emission tomography in the diagnosis of the behavioral variant of frontotemporal dementia.

Kerklaan BJ, van Berckel BN, Herholz K, Dols A, van der Flier WM, Scheltens P, Pijnenburg YA.

Am J Alzheimers Dis Other Demen. 2014 Nov;29(7):607-13. doi: 10.1177/1533317514524811. Epub 2014 Feb 26.

PMID:
24576796
11.

[Frontal variant of frontotemporal dementia].

Boutoleau-Bretonniere C, Lebouvier T, Vercelletto M.

Geriatr Psychol Neuropsychiatr Vieil. 2014 Mar;12(1):63-73. doi: 10.1684/pnv.2014.0451. Review. French.

PMID:
24647240
12.

Characterization of apathy in persons with frontotemporal dementia and the impact on family caregivers.

Merrilees J, Dowling GA, Hubbard E, Mastick J, Ketelle R, Miller BL.

Alzheimer Dis Assoc Disord. 2013 Jan-Mar;27(1):62-7. doi: 10.1097/WAD.0b013e3182471c54.

13.

Fluorodeoxyglucose positron emission tomography in semantic dementia after 6 months of memantine: an open-label pilot study.

Chow TW, Fam D, Graff-Guerrero A, Verhoeff NP, Tang-Wai DF, Masellis M, Black SE, Wilson AA, Houle S, Pollock BG.

Int J Geriatr Psychiatry. 2013 Mar;28(3):319-25. doi: 10.1002/gps.3832. Epub 2012 Jun 4.

14.

Three patients with mood disorders showing catatonia and frontotemporal lobes atrophy.

Utumi Y, Iseki E, Arai H.

Psychogeriatrics. 2013 Dec;13(4):254-9. doi: 10.1111/psyg.12027. Epub 2013 Oct 24.

15.

Building a new paradigm for the early recognition of behavioral variant frontotemporal dementia: Late Onset Frontal Lobe Syndrome study.

Krudop WA, Kerssens CJ, Dols A, Prins ND, Möller C, Schouws S, Barkhof F, van Berckel BN, Teunissen CE, van der Flier WM, Scheltens P, Stek ML, Pijnenburg YA.

Am J Geriatr Psychiatry. 2014 Jul;22(7):735-40. doi: 10.1016/j.jagp.2013.02.002. Epub 2013 Jun 25.

PMID:
23806681
16.

Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia.

Chow TW, Graff-Guerrero A, Verhoeff NP, Binns MA, Tang-Wai DF, Freedman M, Masellis M, Black SE, Wilson AA, Houle S, Pollock BG.

Neuropsychiatr Dis Treat. 2011;7:415-24. doi: 10.2147/NDT.S22635. Epub 2011 Jul 13.

17.

Identifying Specific Clinical Symptoms of Behavioral Variant Frontotemporal Dementia Versus Differential Psychiatric Disorders in Patients Presenting With a Late-Onset Frontal Lobe Syndrome.

Dols A, van Liempt S, Gossink F, Krudop WA, Sikkes S, Pijnenburg YA, Stek ML.

J Clin Psychiatry. 2016 Oct;77(10):1391-1395. doi: 10.4088/JCP.15m09844.

PMID:
27380626
19.

Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia.

Kerchner GA, Tartaglia MC, Boxer A.

Expert Rev Neurother. 2011 May;11(5):709-17. doi: 10.1586/ern.11.6. Review.

20.

Pharmacologic treatment of apathy in dementia.

Berman K, Brodaty H, Withall A, Seeher K.

Am J Geriatr Psychiatry. 2012 Feb;20(2):104-22. doi: 10.1097/JGP.0b013e31822001a6. Review.

PMID:
21841459

Supplemental Content

Support Center